vitronectin antagonist (Bayer)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namevitronectin antagonist (Bayer)

Drug Alias Nameintegrin antagonist (Bayer)biphenylalanine urea derivatives (Bayer)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionIntegrin alpha-V/beta-3 antagonists

TargetsIntegrin alpha-V/beta-3

Therapy Area/IndicationsCoronary Restenosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBayer AG

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBayer AG

Active IndicationsN/A

Inactive IndicationsCoronary Restenosis

ATC CodeN/A